公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | The constituents of Michelia compressa var. Formosana and their bioactivities | Chan Y.-Y.; Juang S.-H.; Huang G.-J.; Liao Y.-R.; Chen Y.-F.; Wu C.-C.; HUI-TING CHANG ; Wu T.-S. | International Journal of Molecular Sciences | |||
2003 | An ecdysone and tetracycline dual regulatory expression system for studies on Rac1 small GTPase-mediated signaling | Lai J.-F.; Juang S.-H.; Hung Y.-M.; Cheng H.-Y.; Cheng T.-L.; Mostov K.E.; TZUU-SHUH JOU | American Journal of Physiology - Cell Physiology | 5 | 5 | |
2004 | Generation of Carcinoembryonic Antigen (CEA)-Specific T-Cell Responses in HLA-A*0201 and HLA-A*2402 Late-Stage Colorectal Cancer Patients after Vaccination with Dendritic Cells Loaded with CEA Peptides | Liu K.-J.; Wang C.-C.; Chen L.-T.; ANN-LII CHENG ; Lin D.-T.; Wu Y.-C.; Yu W.-L.; Hung Y.-M.; Yang H.-Y.; Juang S.-H.; Whang-Peng J. | Clinical Cancer Research | 80 | 76 | |
2012 | Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy | Huang C.-N.; Huang S.-P.; Pao J.-B.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; YEONG-SHIAU PU ; Hsieh C.-J.; Bao B.-Y. | Annals of Oncology | 42 | 39 | |
2012 | Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy | Huang C.-N.; Huang S.-P.; Pao J.-B.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; CHAO-YUAN HUANG ; Hsieh C.-J.; Bao B.-Y. | Journal of Internal Medicine | 32 | 31 | |
2014 | Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer | Huang S.-P.; Levesque E.; Guillemette C.; Yu C.-C.; CHAO-YUAN HUANG ; Lin V.C.; Chung I.-C.; Chen L.-C.; Laverdi?re I.; Lacombe L.; Fradet Y.; Chang T.-Y.; Lee H.-Z.; Juang S.-H.; Bao B.-Y. | International Journal of Cancer | 40 | 34 | |
2013 | Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients | Huang S.-P.; Lin V.C.; Lee Y.-C.; Yu C.-C.; CHAO-YUAN HUANG ; Chang T.-Y.; Lee H.-Z.; Juang S.-H.; Lu T.-L.; Bao B.-Y. | European Journal of Cancer | 19 | 20 | |
2015 | Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer | CHAO-YUAN HUANG ; Huang S.-P.; Lin V.C.; Yu C.-C.; Chang T.-Y.; Juang S.-H.; Bao B.-Y. | Scientific Reports | 20 | 17 | |
2011 | Polymorphisms inside MicroRNAs and MicroRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy | Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU ; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Chen L.-M.; Hsieh C.-J.; Huang S.-P. | Clinical Cancer Research | 64 | 56 | |
2020 | Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation | Juang S.-H.; Hsieh M.-T.; Hsu P.-L.; Chen J.-L.; Liu H.-K.; Liang F.-P.; Kuo S.-C.; Chiu C.-Y.; SHING-HWA LIU ; Chou C.-H.; Wu T.-S.; Hung H.-Y. | Molecules (Basel, Switzerland) | 3 | 3 | |
2013 | Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer | Pao J.-B.; Yang Y.-P.; Huang C.-N.; Huang S.-P.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; CHAO-YUAN HUANG ; Bao B.-Y. | World Journal of Urology | 11 | 10 |